[anonyfox]

actually a difference is also how many players along the supply chain siphon money out of the process. the more greed is allowed and acted on for the treatment, the more expensive it gets. introduce layers of insurances, hedgefonds, pension funds, lobbyism, ... it adds up to riddiculous amounts far beyond the original R&D/infrastructure/treatment costs.

[simondotau]

And those are just the downsides of a market-based system. There are also upsides of single-payer systems, like monopsony buying power.

[philipallstar]

And also downsides, e.g. many treatments just aren't available, and many others would never have had their discovery funded without the market-based system existing.